205 related articles for article (PubMed ID: 6103155)
1. Control of meningococcal infection in the African meningitis belt by selective vaccination.
Greenwood BM; Wali SS
Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
[TBL] [Abstract][Full Text] [Related]
2. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
[TBL] [Abstract][Full Text] [Related]
3. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
4. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
[TBL] [Abstract][Full Text] [Related]
5. Control of epidemic meningococcal meningitis by mass vaccination.
Mohammed I; Zaruba K
Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
[No Abstract] [Full Text] [Related]
6. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
7. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
[TBL] [Abstract][Full Text] [Related]
8. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
[No Abstract] [Full Text] [Related]
9. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
Miller MA; Wenger J; Rosenstein N; Perkins B
Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
[TBL] [Abstract][Full Text] [Related]
10. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.
Bjune G; Høiby EA; Grønnesby JK; Arnesen O; Fredriksen JH; Halstensen A; Holten E; Lindbak AK; Nøkleby H; Rosenqvist E
Lancet; 1991 Nov; 338(8775):1093-6. PubMed ID: 1682541
[TBL] [Abstract][Full Text] [Related]
11. [African aspects of vaccination in prevention of purulent meningitis].
Rey M
Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
[No Abstract] [Full Text] [Related]
12. Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt.
Chippaux JP; Campagne G; Djibo S; Cissé L; Hassane A; Kanta I
Ann Trop Med Parasitol; 1999 Jul; 93(5):505-10. PubMed ID: 10690246
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
14. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
Robbins JB; Towne DW; Gotschlich EC; Schneerson R
Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
[TBL] [Abstract][Full Text] [Related]
15. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
Wu C
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
[TBL] [Abstract][Full Text] [Related]
17. Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.
Masterton RG; Youngs ER; Wardle JC; Croft KF; Jones DM
J Infect; 1988 Sep; 17(2):177-82. PubMed ID: 3141518
[TBL] [Abstract][Full Text] [Related]
18. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
Xu CH
Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
[No Abstract] [Full Text] [Related]
19. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.
Pearce MC; Sheridan JW; Jones DM; Lawrence GW; Murphy DM; Masutti B; McCosker C; Douglas V; George D; O'Keefe A
Lancet; 1995 Jul; 346(8966):20-3. PubMed ID: 7603139
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of group C meningococcal disease in Australian Aboriginal children.
Booy R
Lancet; 1995 Aug; 346(8974):572-3. PubMed ID: 7658793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
